✦ LIBER ✦

The cost of health care for patients with sickle cell disease

✍ Scribed by Samir K. Ballas

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 65 KB
Volume: 84
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21443

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cost of health care for children and

The cost of health care for children and adults with sickle cell disease

✍ Teresa L. Kauf; Thomas D. Coates; Liu Huazhi; Nikita Mody-Patel; Abraham G. Hart 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

## Abstract Although sickle cell disease (SCD) is marked by high utilization of medical resources, the full cost of care for patients with SCD, including care not directly related to SCD, is unknown. The purpose of this study was to estimate the total cost of medical care for a population of childr

Malignancy in patients with sickle cell

Malignancy in patients with sickle cell disease

✍ William H. Schultz; for the International Association of Sickle Cell Nurses; Phy 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Quality of life improvement for patients

Quality of life improvement for patients with sickle cell disease

✍ Leigh T. Ramsey; Kristy F. Woods; Leigh A. Callahan; George A. Mensah; Paule Bar 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

Iron chelation therapy for patients with

Iron chelation therapy for patients with sickle cell disease and iron overload

✍ Adlette Inati; Evelyne Khoriaty; Khaled M. Musallam; Ali T. Taher 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 1 views

Costs and length of stay for patients wi

Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement

✍ Shital Kamble; Marilyn J. Telen; Michaela A. Dinan; Chelsea A. Grussemeyer; Shel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB 👁 1 views

Hospitalization rates and costs of care

Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea

✍ Sophie Lanzkron; Carlton Haywood Jr; Jodi B. Segal; George J. Dover 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract The multicenter study of hydroxyurea (MSH) in sickle‐cell anemia (SCA) demonstrated that patients treated with hydroxyurea (HU) had a 44% decrease in hospitalizations when compared with those taking placebo. A subsequent study looking at the cost‐effectiveness of HU showed that decrease